346 related articles for article (PubMed ID: 30872401)
1. Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-β oligomers.
Jarosz-Griffiths HH; Corbett NJ; Rowland HA; Fisher K; Jones AC; Baron J; Howell GJ; Cowley SA; Chintawar S; Cader MZ; Kellett KAB; Hooper NM
J Biol Chem; 2019 Apr; 294(17):7085-7097. PubMed ID: 30872401
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
3. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.
Taylor DR; Parkin ET; Cocklin SL; Ault JR; Ashcroft AE; Turner AJ; Hooper NM
J Biol Chem; 2009 Aug; 284(34):22590-600. PubMed ID: 19564338
[TBL] [Abstract][Full Text] [Related]
4. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
[TBL] [Abstract][Full Text] [Related]
5. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Corbett GT; Gonzalez FJ; Pahan K
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
[TBL] [Abstract][Full Text] [Related]
6. Peptide aptamer targeting Aβ-PrP-Fyn axis reduces Alzheimer's disease pathologies in 5XFAD transgenic mouse model.
Ali T; Klein AN; Vu A; Arifin MI; Hannaoui S; Gilch S
Cell Mol Life Sci; 2023 May; 80(6):139. PubMed ID: 37149826
[TBL] [Abstract][Full Text] [Related]
7. The sheddase ADAM10 is a potent modulator of prion disease.
Altmeppen HC; Prox J; Krasemann S; Puig B; Kruszewski K; Dohler F; Bernreuther C; Hoxha A; Linsenmeier L; Sikorska B; Liberski PP; Bartsch U; Saftig P; Glatzel M
Elife; 2015 Feb; 4():. PubMed ID: 25654651
[TBL] [Abstract][Full Text] [Related]
8. Octyl gallate markedly promotes anti-amyloidogenic processing of APP through estrogen receptor-mediated ADAM10 activation.
Zhang SQ; Sawmiller D; Li S; Rezai-Zadeh K; Hou H; Zhou S; Shytle D; Giunta B; Fernandez F; Mori T; Tan J
PLoS One; 2013; 8(8):e71913. PubMed ID: 23977176
[TBL] [Abstract][Full Text] [Related]
9. The prion protein ligand, stress-inducible phosphoprotein 1, regulates amyloid-β oligomer toxicity.
Ostapchenko VG; Beraldo FH; Mohammad AH; Xie YF; Hirata PH; Magalhaes AC; Lamour G; Li H; Maciejewski A; Belrose JC; Teixeira BL; Fahnestock M; Ferreira ST; Cashman NR; Hajj GN; Jackson MF; Choy WY; MacDonald JF; Martins VR; Prado VF; Prado MA
J Neurosci; 2013 Oct; 33(42):16552-64. PubMed ID: 24133259
[TBL] [Abstract][Full Text] [Related]
10. Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein.
Mohammadi B; Song F; Matamoros-Angles A; Shafiq M; Damme M; Puig B; Glatzel M; Altmeppen HC
Cell Tissue Res; 2023 Apr; 392(1):215-234. PubMed ID: 35084572
[TBL] [Abstract][Full Text] [Related]
11. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695.
Peng Y; Lee DY; Jiang L; Ma Z; Schachter SC; Lemere CA
Neuroscience; 2007 Dec; 150(2):386-95. PubMed ID: 17945434
[TBL] [Abstract][Full Text] [Related]
12. Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells.
Panmanee J; Nopparat C; Chavanich N; Shukla M; Mukda S; Song W; Vincent B; Govitrapong P
J Pineal Res; 2015 Oct; 59(3):308-20. PubMed ID: 26123100
[TBL] [Abstract][Full Text] [Related]
13. Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein.
Linsenmeier L; Mohammadi B; Wetzel S; Puig B; Jackson WS; Hartmann A; Uchiyama K; Sakaguchi S; Endres K; Tatzelt J; Saftig P; Glatzel M; Altmeppen HC
Mol Neurodegener; 2018 Apr; 13(1):18. PubMed ID: 29625583
[TBL] [Abstract][Full Text] [Related]
14. Gallic acid is a dual α/β-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice.
Mori T; Koyama N; Yokoo T; Segawa T; Maeda M; Sawmiller D; Tan J; Town T
J Biol Chem; 2020 Nov; 295(48):16251-16266. PubMed ID: 32913125
[TBL] [Abstract][Full Text] [Related]
15. Tetraspanin 3: A central endocytic membrane component regulating the expression of ADAM10, presenilin and the amyloid precursor protein.
Seipold L; Damme M; Prox J; Rabe B; Kasparek P; Sedlacek R; Altmeppen H; Willem M; Boland B; Glatzel M; Saftig P
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):217-230. PubMed ID: 27818272
[TBL] [Abstract][Full Text] [Related]
16. Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer.
Tsang JYS; Lee MA; Chan TH; Li J; Ni YB; Shao Y; Chan SK; Cheungc SY; Lau KF; Tse GMK
EBioMedicine; 2018 Dec; 38():89-99. PubMed ID: 30470613
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin.
Tippmann F; Hundt J; Schneider A; Endres K; Fahrenholz F
FASEB J; 2009 Jun; 23(6):1643-54. PubMed ID: 19144697
[TBL] [Abstract][Full Text] [Related]
18. Surface expression and limited proteolysis of ADAM10 are increased by a dominant negative inhibitor of dynamin.
Carey RM; Blusztajn JK; Slack BE
BMC Cell Biol; 2011 May; 12():20. PubMed ID: 21586144
[TBL] [Abstract][Full Text] [Related]
19. A novel blood-brain barrier co-culture system for drug targeting of Alzheimer's disease: establishment by using acitretin as a model drug.
Freese C; Reinhardt S; Hefner G; Unger RE; Kirkpatrick CJ; Endres K
PLoS One; 2014; 9(3):e91003. PubMed ID: 24608847
[TBL] [Abstract][Full Text] [Related]
20. Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of β-amyloid found in Alzheimer disease.
Al-Atrache Z; Lopez DB; Hingley ST; Appelt DM
BMC Neurosci; 2019 Feb; 20(1):6. PubMed ID: 30786875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]